BioMedomics Faces $6.1M Suit Over COVID-19 Antibody Test
Becton Dickinson & Co. says it's owed more than $6 million because BioMedomics Inc. developed a COVID-19 antibody test that failed to get U.S. Food and Drug Administration clearance, according to...To view the full article, register now.
Already a subscriber? Click here to view full article